This company listing is no longer active
Salud financiera de hoja de balance de IVERIC bio
Salud financiera controles de criterios 5/6
IVERIC bio has a total shareholder equity of $477.0M and total debt of $97.0M, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are $613.4M and $136.4M respectively.
Información clave
20.3%
Ratio deuda-patrimonio
US$96.99m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$599.92m |
| Patrimonio | US$477.05m |
| Total pasivo | US$136.36m |
| Activos totales | US$613.41m |
Actualizaciones recientes sobre salud financiera
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: O2T's short term assets ($611.5M) exceed its short term liabilities ($39.4M).
Pasivo a largo plazo: O2T's short term assets ($611.5M) exceed its long term liabilities ($97.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: O2T has more cash than its total debt.
Reducción de la deuda: O2T's debt to equity ratio has reduced from 445.2% to 20.3% over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: O2T has sufficient cash runway for more than 3 years based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if O2T has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.